Article info

other Versions

Download PDFPDF
Phase II consolidation trial with anti-Lewis-Y monoclonal antibody (hu3S193) in platinum-sensitive ovarian cancer after a second remission

Authors

  1. Correspondence to Dr Oren Smaletz, Oncology Department, Hospital Israelita Albert Einstein, Sao Paulo 05651-901, Brazil; oren.smaletz{at}einstein.br
View Full Text

Citation

Smaletz O, Ismael G, Del Pilar Estevez-Diz M, et al
Phase II consolidation trial with anti-Lewis-Y monoclonal antibody (hu3S193) in platinum-sensitive ovarian cancer after a second remission

Publication history

  • Received November 10, 2020
  • Revision received February 18, 2021
  • Accepted February 19, 2021
  • First published March 4, 2021.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.